Notably, Cai and colleagues previously reported that PEDF expression was significantly reduced in breast cancer tissues compared with normal breast tissue [24]; however, these investigators did not examine whether PEDF expression correlated with response to endocrine therapy or acquired resistance. This evidence concerns the gene SERPINF1 and breast cancer.